Full-Time

Lead AI Engineer

AlphaLife Sciences

AlphaLife Sciences

11-50 employees

AI-driven clinical development and regulatory writing

Compensation Overview

$150k - $230k/yr

No H1B Sponsorship

Jersey City, NJ, USA

Hybrid

Hybrid work in Jersey City.

Bachelor's, Master's

Category
AI & Machine Learning (1)
Required Skills
LLM
Python
Distributed Systems
Machine Learning
Java
RAG
C/C++
Data Analysis

Get referred to AlphaLife Sciences

See people who can refer or advise you

Requirements
  • A Bachelor's or Master's degree in Computer Science, AI/ML, Data Science, or a related field is required.
  • At least 6 years of software engineering experience, including at least 3 years leading AI/ML initiatives, products, or teams, is required.
  • Strong programming skills in Python and at least one additional language such as Java or C++ are required.
  • Hands-on experience with Generative AI, large language models, retrieval-augmented generation, AI agents, model evaluation, and related AI technologies is required.
  • Experience building, deploying, and maintaining AI systems in production environments is required.
  • The candidate must be able to lead technical initiatives, drive architectural decisions, and mentor engineers.
  • The candidate must be able to communicate and collaborate cross-functionally with Product, Engineering, and business stakeholders.
  • The candidate must be comfortable working in a fast-paced startup environment with ambiguity and evolving priorities.
  • Applicants must be authorized to work in the United States without the need for current or future visa sponsorship.
Responsibilities
  • Lead a small team of AI engineers and guide their development on project tasks.
  • Design, develop, and prototype AI and large language model solutions for real-world clinical workflows.
  • Collaborate closely with Product Managers and cross-functional teams to implement innovative AI solutions.
  • Mentor junior engineers and support skill development and productivity.
  • Stay up to date with cutting-edge artificial intelligence and machine learning research and apply relevant advances to projects.
Desired Qualifications
  • Experience in clinical workflows, clinical trials, or life sciences applications.
  • Data analysis, cloud development, or distributed systems experience.
  • Experience deploying AI solutions in production.

Automates medical writing and regulatory documentation for clinical development through its AuroraPrime platform, using Agentic AI to generate and organize content. It helps speed drug R&D and regulatory submissions across therapeutic areas. It differentiates itself with partnerships including Microsoft as Global AI Content Automation Partner for Life Sciences and programs from Johnson & Johnson Innovation JLABS, Google for Startups, Nvidia Inception, and Veeva AI. The goal is to accelerate drug development and regulatory submissions so patients can access therapies sooner.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Singapore, Singapore

Founded

2020

Get referred to AlphaLife Sciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 2026 AuroraPrime release added Document Library and 5,000-row TFL support.
  • Updated 2025 review says Veeva AI Partner Program expanded ecosystem reach.
  • Auto-citation and source verification cut six-month CSR cycles to weeks for pharma teams.

What critics are saying

  • 2021 RMB 100 million financing is old; no newer independent funding round appears.
  • No verified layoffs, customer count, or revenue disclosures limit conviction on scale.
  • Veeva and Microsoft integrations create platform dependence; a partner shift would cripple distribution.

What makes AlphaLife Sciences unique

  • AuroraPrime RMA automates regulatory authoring, QC, and CSR generation with audit trails.
  • March 30, 2026 Veeva RIM integration embeds Agentic AI into regulatory workflows.
  • Microsoft AppSource and Microsoft Ignite 2025 visibility signal enterprise-grade cloud credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

Flexible Work Hours

Company Equity

Professional Development Budget

Company News

AlphaLife Sciences
Feb 12th, 2026
Redefining Regulatory Integrity: Key Takeaways from AlphaLife Sciences at Microsoft Ignite 2025

Redefining regulatory integrity: key takeaways from AlphaLife Sciences at Microsoft Ignite 2025. Feb 12, 2026 What does regulatory integrity look like in the age of AI? At Microsoft Ignite 2025, AlphaLife Sciences took the stage to explore how intelligent platforms, structured data, and responsible AI are redefining the regulatory landscape - not just improving efficiency, but fundamentally elevating quality, traceability, and trust. The energy in San Francisco this past November was electric. At Microsoft Ignite 2025, the conversation wasn't just about what AI could do in the future - it was about what it is doing right now to transform industries. For the life sciences sector, the stakes have never been higher. With R&D pipelines expanding fourfold since 2001 and the cost of bringing a drug to market continuing to climb, the industry is at a breaking point. AlphaLife Sciences LLC can no longer afford the status quo of manual data transcription and months-long authoring cycles. At AlphaLife Sciences, AlphaLife Sciences LLC believe the answer lies in Agentic AI - intelligent agents that don't just generate text, but understand the rigorous "blueprints" of regulatory science. If you missed its session, "The blueprint for intelligent AI agents backed by PostgreSQL," here is a recap of how AlphaLife Sciences LLC is rewriting the rules of regulatory documentation alongside its partners at Microsoft. The "three hurdles" of pharma AI. During the session, its Founder and CEO, Sharon Chen, took the stage with Microsoft leaders Maxim Lukiyanov and Abe Omorogbe to address the elephant in the room: Why is it so hard to apply GenAI to regulatory documents? It comes down to three specific hurdles: * Massive Data Volume: A single study generates hundreds of thousands of files - from PDFs to XMLs. * Strict Compliance: "Close enough" doesn't count in regulatory affairs. Every claim must be traceable. * Zero Tolerance for Errors: In an industry where patient safety is paramount, AI hallucinations are not an option. As Sharon noted, the complexity of clinical documentation requires more than a chatbot. It requires intelligent agents that understand data structures, regulatory logic, and version control. A database is more than storage - It's knowledge. One of the most widely discussed insights from its presentation was a fundamental shift in how AlphaLife Sciences LLC view infrastructure. Sharon argued that "A database is not just for storage - it is the semantic knowledge foundation for AI". By building its AuroraPrime platform on a robust architecture involving Azure and PostgreSQL, AlphaLife Sciences LLC allow AI agents to do something remarkable: they can "think" relationally. This means the AI doesn't just guess the next word; it retrieves the correct data, verifies the source, and ensures that a number in the text matches the number in the table. From six months to weeks: the real-world impact. AlphaLife Sciences LLC didn't just talk theory; AlphaLife Sciences LLC showed the engine in action. The session featured a demonstration of end-to-end protocol automation that illustrated exactly how these agents work as "digital coworkers". Imagine drafting a Clinical Study Report (CSR) - a process that traditionally consumes up to six months. Its agents can: * Draft and refine sections by pulling directly from a centralized reference pool. * Auto-cite sources, providing a clear audit trail for human reviewers. * Intelligently handle amendments, identifying which sections need to change based on new data. The potential impact? Cutting authoring timelines by half or more, translating to billions in time and cost savings for large pharmaceutical companies. Watch the full session. The era of intelligent cloud technology is here, and it is ready for the enterprise. At AlphaLife Sciences, its goal isn't to replace human expertise but to extend it - creating systems that are structured, compliant, and safe. If you are ready to see the blueprint for the future of regulatory writing, AlphaLife Sciences LLC invite you to watch the full session recording and download the slide deck. Let's build a future where AlphaLife Sciences LLC spend less time on paperwork and more time on patients.

AlphaLife Sciences
Sep 1st, 2025
Elevate Your Regulatory Journey Unveiling AuroraPrime RMA's Latest Release

Critically, AlphaLife Sciences LLC has introduced a new "Project Creator" role, allowing designated users to create new Writing Projects directly in the add-in.

AlphaLife Sciences
Aug 7th, 2025
The Latest AuroraPrime RMA Update: AI-Driven Authoring Just Got Better

AlphaLife Sciences LLC is excited to unveil the latest AuroraPrime RMA release, packed with powerful new enhancements designed to empower clinical operations, medical writing, and regulatory affairs teams like never before.

AlphaLife Sciences
Jan 17th, 2025
AlphaLife Sciences Engages with Global Industry Leaders at Biotech Showcase 2025 in San Francisco

AlphaLife Sciences actively participated in the Biotech Showcase 2025, held from January 13 to 15 in San Francisco.

AlphaLife Sciences
Sep 5th, 2023
AlphaPrime Life Sciences Collaborates with LUNAN PHARMACEUTICAL GROUP to Empower Efficient Medical Team Writing and Collaboration.

AlphaPrime Life Sciences collaborates with LUNAN PHARMACEUTICAL GROUP to empower efficient medical team writing and collaboration.